跳至主要内容
临床试验/NCT00159146
NCT00159146终止不适用

A Short Term Double Blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Hillerod Hospital, Denmark1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2002年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
31
试验地点
1
主要终点
Hamilton Depression Rating Scale scores

研究概览

简要总结

This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.

详细描述

Antidepressant therapy has a delayed onset of action of 4-6 weeks. Pindolol has in some studies shown an accelerating effect. In this study we investigate the effect of 20 mg of pindolol retarded formulation in combination with Venlafaxine compared to placebo Pindolol and Venlafaxine for a duration of 19 days.

Effect is measured by the Hamilton Depression rating Scale and the Preskorn Scale (self-rating).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major depression

排除标准

  • Allergy towards pindolol, venlafaxine or other tablet constituents
  • Liver or kidney impairment
  • Diabetics
  • Age below 18 years
  • Severe cardiac disease

研究组 & 干预措施

A

Active Comparator

Venlafaxine and pindolol

干预措施: Pindolol and venlafaxin (Drug)

B

Placebo Comparator

Venlafaxin and placebo

干预措施: Pindolol and venlafaxin (Drug)

结局指标

主要结局

Hamilton Depression Rating Scale scores

时间窗: 1 week

次要结局

  • Preskorn scores(one day)

研究者

发起方
Hillerod Hospital, Denmark
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Trial of Pindolol Augmentation in Venlafaxine... | 临床试验